The effect of previous SARSCoV-2 infection on systemic immune responses in individuals with tuberculosis.

Autor: Xavier, Mariana S., Araujo-Pereira, Mariana, de Oliveira, Quezia M., Sant’Anna, Flavia M., Ridolfi, Felipe M., de Andrade, Alice M. S., Figueiredo, Marina C., Sterling, Timothy R., Gordhan, Bhavna G., Kana, Bavesh D., Andrade, Bruno B., Rolla, Valeria C., Gomes-Silva, Adriano

Publikováno v: Frontiers in Immunology; 2024, p1-11, 11p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.

Autor: Peetluk LS; Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Rebeiro PF; Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Ridolfi FM; Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil., Andrade BB; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Instituto Brasileiro para Investigação da Tuberculose, Fundação José Silveira, Salvador, Bahia, Brazil.; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Universidade Salvador, Laureate Universities, Salvador, Bahia, Brazil.; Escola Bahiana de Medicina e Saúde Pública, Salvador, Bahia, Brazil.; Curso de Medicina, Faculdade de Tecnologia e Ciências, Salvador, Bahia, Brazil., Cordeiro-Santos M; Fundação Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.; Universidade do Estado do Amazonas, Manaus, Brazil., Kritski A; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Rio de Janeiro, Brazil., Durovni B; Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil., Calvacante S; Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Rio de Janeiro, Brazil., Figueiredo MC; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Haas DW; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Department of Internal Medicine, Meharry Medical College, Nashville, Tennessee, USA., Liu D; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Rolla VC; Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil., Sterling TR; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Mar 23; Vol. 74 (6), pp. 973-982.